Victory Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $82.2K | Buy |
17,608
+484
| +3% | +$2.26K | ﹤0.01% | 2346 |
|
2025
Q1 | $94K | Sell |
17,124
-361
| -2% | -$1.98K | ﹤0.01% | 2315 |
|
2024
Q4 | $59.3K | Sell |
17,485
-33
| -0.2% | -$112 | ﹤0.01% | 2374 |
|
2024
Q3 | $49.9K | Sell |
17,518
-366
| -2% | -$1.04K | ﹤0.01% | 2393 |
|
2024
Q2 | $40.2K | Buy |
17,884
+529
| +3% | +$1.19K | ﹤0.01% | 2387 |
|
2024
Q1 | $38.4K | Sell |
17,355
-99
| -0.6% | -$219 | ﹤0.01% | 2397 |
|
2023
Q4 | $41K | Buy |
17,454
+3,343
| +24% | +$7.86K | ﹤0.01% | 2456 |
|
2023
Q3 | $26.2K | Buy |
14,111
+413
| +3% | +$768 | ﹤0.01% | 2434 |
|
2023
Q2 | $35.9K | Sell |
13,698
-319
| -2% | -$836 | ﹤0.01% | 2418 |
|
2023
Q1 | $22.8K | Sell |
14,017
-487
| -3% | -$794 | ﹤0.01% | 2501 |
|
2022
Q4 | $19.3K | Sell |
14,504
-6
| -0% | -$8 | ﹤0.01% | 2513 |
|
2022
Q3 | $23K | Sell |
14,510
-2,245
| -13% | -$3.56K | ﹤0.01% | 2617 |
|
2022
Q2 | $26K | Sell |
16,755
-62
| -0.4% | -$96 | ﹤0.01% | 2597 |
|
2022
Q1 | $41K | Buy |
16,817
+852
| +5% | +$2.08K | ﹤0.01% | 2610 |
|
2021
Q4 | $47K | Buy |
+15,965
| New | +$47K | ﹤0.01% | 2648 |
|
2021
Q2 | – | Sell |
-10,236
| Closed | -$46K | – | 2815 |
|
2021
Q1 | $46K | Buy |
+10,236
| New | +$46K | ﹤0.01% | 2673 |
|
2020
Q2 | – | Sell |
-10,912
| Closed | -$22K | – | 3306 |
|
2020
Q1 | $22K | Buy |
+10,912
| New | +$22K | ﹤0.01% | 3065 |
|
2019
Q4 | – | Sell |
-3,105
| Closed | -$31K | – | 3298 |
|
2019
Q3 | $31K | Buy |
+3,105
| New | +$31K | ﹤0.01% | 2894 |
|
2019
Q2 | – | Sell |
-3,454
| Closed | -$35K | – | 1864 |
|
2019
Q1 | $35K | Hold |
3,454
| – | – | ﹤0.01% | 1727 |
|
2018
Q4 | $59K | Hold |
3,454
| – | – | ﹤0.01% | 1680 |
|
2018
Q3 | $61K | Buy |
3,454
+454
| +15% | +$8.02K | ﹤0.01% | 1709 |
|
2018
Q2 | $57K | Buy |
+3,000
| New | +$57K | ﹤0.01% | 1749 |
|